Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Levulan Articles

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million

9 November 2012

US FDA says no to orphan status for DUSA Pharma’s skin cancer drug Levulan

10 August 2010

Intendis licenses Photonamic's 5-ALA patch

29 September 2008

DUSA in deal with Stiefel for Levulan Kerastick PDT

30 January 2006

Australian patent ruling on Metvix

11 April 2005

Schering and DUSA to test Levulan in acne

30 November 2000

Schering's topical PDT therapy gets US approval for AKs

28 September 2000

Schering to market DUSA's Levulan

25 November 1999

DUSA's Levulan application

2 July 1998

1991 MARKED SIGNIFICANT YEAR FOR DEPRENYL

4 May 1992

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS